-
1دورية أكاديمية
المؤلفون: AL-Suraify, Sajida Munadi Th.Aff1, IDs13204021020803_cor1, Hussien, Lamees Bassim
المصدر: Applied Nanoscience. 13(3):2083-2092
-
2كتاب إلكتروني
المؤلفون: Lu, FeipengAff3, Li, ShenghuaAff4, Chen, JianhuaAff3, He, AifengAff3, Wang, YinAff3
المساهمون: Gany, Alon, editorAff1, Fu, Xiaolong, editorAff2
المصدر: 2021 International Conference on Development and Application of Carbon Nanomaterials in Energetic Materials. 276:481-493
-
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4
المؤلفون: Zeng, S., Dou, W., Li, M., Zhou, Yang, 1989, Guo, J., Zhao, N., Huang, H., Zhou, Q., Hu, W., Ma, Y., Zhao, X., Xie, H.
المصدر: ChemMedChem. 15(16):1608-1617
مصطلحات موضوعية: biostability, DPP-IV, in silico testing, inhibitors, metabolism, 2 [[2 (3 aminopiperidin 1 yl) 4 oxo 6 (1h pyrazol 4 yl)thieno[3, 2 d]pyrimidin 3(4h) yl]methyl] 4 fluorobenzonitrile, 2 [[2 (3 aminopiperidin 1 yl) 4 oxo 6 (pyridin 3 yl)thieno[3, 2 [[2 (3 aminopiperidin 1 yl) 4 oxo 6 (pyridin 4 yl)thieno[3, 2 [[2 (3 aminopiperidin 1 yl) 4 oxo 6 [3 (trifluoromethyl)phenyl]thieno[3, 2 [[2 (3 aminopiperidin 1 yl) 4 oxo 7 (pyridin 3 yl)thieno[3, 2 [[2 (3 aminopiperidin 1 yl) 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 (2 methoxypyridin 4 yl) 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 (2 methylpyridin 4 yl) 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 (3 fluorophenyl) 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 (3, 5 dimethylisoxazol 4 yl) 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 (4 fluorophenyl) 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 bromo 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 [3 (methylsulfonyl)phenyl] 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 7 bromo 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 7 fluoro 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 7 methyl 4 oxo 6 (pyridin 3 yl)thieno[3, 2 [[2 (3 aminopiperidin 1 yl) 7 methyl 4 oxothieno[3, antidiabetic agent, cytochrome P450, dipeptidyl peptidase IV inhibitor, long acting drug, pyrimidine derivative, trelagliptin, unclassified drug, xanthine derivative, animal experiment, area under the curve, Article, computer model, controlled study, drug bioavailability, drug design, drug efficacy, drug half life, drug potency, drug transformation, glycemic control, IC50, in vitro study, in vivo study, infant, male, maximum plasma concentration, mean residence time, metabolic stability, nonhuman, priority journal, rat, time to maximum plasma concentration
وصف الملف: print
-
5دورية أكاديمية
المؤلفون: Abushamleh, A. S.Aff1, Abu-Safieh, K. A., Khanfar, M. A., Taher, D., Tahtamouni, L., Alwahsh, N. J.
المصدر: Journal of Structural Chemistry. 62(7):1112-1122
-
6كتاب إلكتروني
المؤلفون: Pardasani, R. T.Aff10, Pardasani, P.Aff20
المساهمون: Pardasani, R. T.Aff1, Pardasani, P.Aff2, Gupta, A., editorAff3
المصدر: Magnetic Properties of Paramagnetic Compounds, Magnetic Susceptibility Data, Volume 4 : A Supplement to Landolt-Börnstein II/31 Series. :1303-1305
-
7دورية أكاديمية
المؤلفون: Shaimaa Mohsen. Essa, Wisam Hindawi Hoidy
المصدر: Nano Biomedicine and Engineering, Vol 12, Iss 2, Pp 160-166 (2020)
مصطلحات موضوعية: heterocyclic, pyrazol, azo, antipyrene, antimicrobial, antioxidants, Biology (General), QH301-705.5, Medicine
وصف الملف: electronic resource
-
8دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
9دورية أكاديمية
المؤلفون: Ahmadian, Fatemeh, Barmak, Alireza, Ghaderi, Esmali, Bavadi, Masoumeh, Raanaei, Hossein, Niknam, KhodabakhshAff1
المصدر: Journal of the Iranian Chemical Society. 16(12):2647-2658
-
10دورية أكاديمية
المؤلفون: Gandhi, Sahaj A.Aff1, Patel, Urmila H., Barot, V. M., Varma, N. V. S.
المصدر: Indian Journal of Physics. 93(10):1275-1291